Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Aug;92(2):1009–1017. doi: 10.1172/JCI116606

Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

D J Rader 1, J Schäfer 1, P Lohse 1, B Verges 1, M Kindt 1, L A Zech 1, A Steinmetz 1, H B Brewer Jr 1
PMCID: PMC294942  PMID: 8349786

Abstract

Apolipoprotein (apo) A-IV is a polymorphic, intestinally derived apolipoprotein that is genetically linked to and similar in structure to apoA-I, the major apolipoprotein in high density lipoproteins (HDL). ApoA-IV plays a potentially important role in lipoprotein metabolism and reverse cholesterol transport, but its in vivo metabolism is poorly understood. In order to gain insight into factors modulating apoA-IV metabolism in humans, the in vivo kinetics of the two major human apoA-IV isoproteins apoA-IV-1 and apoA-IV-2 were investigated in normolipidemic human subjects. 131I-apoA-IV-1 and 125I-apoA-IV-2 were reassociated with autologous plasma and injected into study subjects. Analysis of the kinetic data revealed a rapid mean fractional catabolic rate (FCR) for apoA-IV-1 of 2.42 +/- 0.11 d-1. The mean production, or transport, rate of apoA-IV-1 was 16.3 +/- 1.4 mg/kg per d. Plasma apoA-IV concentrations were highly correlated with apoA-IV production rate (r = 0.84, P < 0.001) and not correlated with apoA-IV fractional catabolic rate (r = 0.25, P = NS). The mean FCR of apoA-IV-2 was 2.21 +/- 0.10 d-1. In the ten subjects in whom 131I-apoA-IV-1 and 125I-apoA-IV-2 were simultaneously injected, the FCR of apoA-IV-2 was significantly slower by paired t test (P = 0.003). The FCR of apoA-IV-2 in an apoA-IV-2/2 homozygote was only 1.49 d-1, substantially slower than in all other subjects. We conclude that: (a) apoA-IV is a rapidly catabolized apolipoprotein in humans, with a fractional catabolic rate more than 10 times greater than that of apoA-I; (b) apoA-IV has a high absolute transport rate similar to that of apoA-I; (c) plasma levels of apoA-IV are primarily determined by apoA-IV production rate in normolipidemic subjects; and (d) the fractional catabolic rate of the common variant apoA-IV-2 is slower than that of the wild-type apoA-IV-1.

Full text

PDF
1009

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barter P. J., Rajaram O. V., Chang L. B., Rye K. A., Gambert P., Lagrost L., Ehnholm C., Fidge N. H. Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator. Biochem J. 1988 Aug 15;254(1):179–184. doi: 10.1042/bj2540179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beisiegel U., Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem. 1979 Feb 1;93(3):601–608. doi: 10.1111/j.1432-1033.1979.tb12860.x. [DOI] [PubMed] [Google Scholar]
  3. Betard C., Vu-Dac N., Mezdour H., Nestruck A. C., Leroy A., Fruchart J. C. Standardization of an enzymometric assay for apolipoprotein A-I by using mixtures of monoclonal antibodies). J Clin Chem Clin Biochem. 1987 Dec;25(12):893–899. doi: 10.1515/cclm.1987.25.12.893. [DOI] [PubMed] [Google Scholar]
  4. Bisgaier C. L., Sachdev O. P., Lee E. S., Williams K. J., Blum C. B., Glickman R. M. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J Lipid Res. 1987 Jun;28(6):693–703. [PubMed] [Google Scholar]
  5. Bisgaier C. L., Sachdev O. P., Megna L., Glickman R. M. Distribution of apolipoprotein A-IV in human plasma. J Lipid Res. 1985 Jan;26(1):11–25. [PubMed] [Google Scholar]
  6. Bisgaier C. L., Siebenkas M. V., Hesler C. B., Swenson T. L., Blum C. B., Marcel Y. L., Milne R. W., Glickman R. M., Tall A. R. Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins. J Lipid Res. 1989 Jul;30(7):1025–1031. [PubMed] [Google Scholar]
  7. Boerwinkle E., Visvikis S., Chan L. Two polymorphisms for amino acid substitutions in the APOA4 gene. Nucleic Acids Res. 1990 Aug 25;18(16):4966–4966. doi: 10.1093/nar/18.16.4966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brinton E. A., Eisenberg S., Breslow J. L. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest. 1990 Jan;85(1):144–151. doi: 10.1172/JCI114405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brinton E. A., Eisenberg S., Breslow J. L. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest. 1989 Jul;84(1):262–269. doi: 10.1172/JCI114149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brinton E. A., Eisenberg S., Breslow J. L. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 1991 Feb;87(2):536–544. doi: 10.1172/JCI115028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chen C. H., Albers J. J. Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta. 1985 Oct 2;836(3):279–285. doi: 10.1016/0005-2760(85)90131-6. [DOI] [PubMed] [Google Scholar]
  12. Duverger N., Ghalim N., Ailhaud G., Steinmetz A., Fruchart J. C., Castro G. Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler Thromb. 1993 Jan;13(1):126–132. doi: 10.1161/01.atv.13.1.126. [DOI] [PubMed] [Google Scholar]
  13. Duverger N., Ghalim N., Theret N., Duchateau P., Aguie G., Ailhaud G., Castro G., Fruchart J. C. Lipoprotein A-I containing particles. Adv Exp Med Biol. 1991;285:93–99. doi: 10.1007/978-1-4684-5904-3_12. [DOI] [PubMed] [Google Scholar]
  14. Dvorin E., Gorder N. L., Benson D. M., Gotto A. M., Jr Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem. 1986 Nov 25;261(33):15714–15718. [PubMed] [Google Scholar]
  15. Eichner J. E., Kuller L. H., Ferrell R. E., Kamboh M. I. Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol. 1989;6(4):493–499. doi: 10.1002/gepi.1370060404. [DOI] [PubMed] [Google Scholar]
  16. Elshourbagy N. A., Walker D. W., Boguski M. S., Gordon J. I., Taylor J. M. The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III. J Biol Chem. 1986 Feb 15;261(5):1998–2002. [PubMed] [Google Scholar]
  17. Ghiselli G., Krishnan S., Beigel Y., Gotto A. M., Jr Plasma metabolism of apolipoprotein A-IV in humans. J Lipid Res. 1986 Aug;27(8):813–827. [PubMed] [Google Scholar]
  18. Goldberg I. J., Scheraldi C. A., Yacoub L. K., Saxena U., Bisgaier C. L. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem. 1990 Mar 15;265(8):4266–4272. [PubMed] [Google Scholar]
  19. Green P. H., Glickman R. M., Riley J. W., Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest. 1980 Apr;65(4):911–919. doi: 10.1172/JCI109745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Green P. H., Glickman R. M., Saudek C. D., Blum C. B., Tall A. R. Human intestinal lipoproteins. Studies in chyluric subjects. J Clin Invest. 1979 Jul;64(1):233–242. doi: 10.1172/JCI109444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kamboh M. I., Ferrell R. E. Genetic studies of human apolipoproteins. I. Polymorphism of apolipoprotein A-IV. Am J Hum Genet. 1987 Aug;41(2):119–127. [PMC free article] [PubMed] [Google Scholar]
  23. Karathanasis S. K., Oettgen P., Haddad I. A., Antonarakis S. E. Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4). Proc Natl Acad Sci U S A. 1986 Nov;83(22):8457–8461. doi: 10.1073/pnas.83.22.8457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Karathanasis S. K., Yunis I., Zannis V. I. Structure, evolution, and tissue-specific synthesis of human apolipoprotein AIV. Biochemistry. 1986 Jul 1;25(13):3962–3970. doi: 10.1021/bi00361a034. [DOI] [PubMed] [Google Scholar]
  25. Kraft H. G., Menzel H. J., Hoppichler F., Vogel W., Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest. 1989 Jan;83(1):137–142. doi: 10.1172/JCI113849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lagrost L., Gambert P., Boquillon M., Lallemant C. Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum. J Lipid Res. 1989 Oct;30(10):1525–1534. [PubMed] [Google Scholar]
  27. Lagrost L., Gambert P., Dangremont V., Athias A., Lallemant C. Role of cholesteryl ester transfer protein (CETP) in the HDL conversion process as evidenced by using anti-CETP monoclonal antibodies. J Lipid Res. 1990 Sep;31(9):1569–1575. [PubMed] [Google Scholar]
  28. Lohse P., Kindt M. R., Rader D. J., Brewer H. B., Jr Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem. 1990 Jun 15;265(17):10061–10064. [PubMed] [Google Scholar]
  29. Lohse P., Kindt M. R., Rader D. J., Brewer H. B., Jr Human plasma apolipoproteins A-IV-0 and A-IV-3. Molecular basis for two rare variants of apolipoprotein A-IV-1. J Biol Chem. 1990 Jul 25;265(21):12734–12739. [PubMed] [Google Scholar]
  30. Malmendier C. L., Lontie J. F., Lagrost L., Delcroix C., Dubois D. Y., Gambert P. In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects. J Lipid Res. 1991 May;32(5):801–808. [PubMed] [Google Scholar]
  31. Menzel H. J., Boerwinkle E., Schrangl-Will S., Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet. 1988 Aug;79(4):368–372. doi: 10.1007/BF00282179. [DOI] [PubMed] [Google Scholar]
  32. Menzel H. J., Kövary P. M., Assmann G. Apolipoprotein A-IV polymorphism in man. Hum Genet. 1982;62(4):349–352. doi: 10.1007/BF00304554. [DOI] [PubMed] [Google Scholar]
  33. Menzel H. J., Sigurdsson G., Boerwinkle E., Schrangl-Will S., Dieplinger H., Utermann G. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet. 1990 Mar;84(4):344–346. doi: 10.1007/BF00196231. [DOI] [PubMed] [Google Scholar]
  34. Ohta T., Fidge N. H., Nestel P. J. Characterization of apolipoprotein A-IV complexes and A-IV isoforms in human lymph and plasma lipoproteins. J Biol Chem. 1984 Dec 10;259(23):14888–14893. [PubMed] [Google Scholar]
  35. Ohta T., Fidge N. H., Nestel P. J. Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. J Clin Invest. 1985 Sep;76(3):1252–1260. doi: 10.1172/JCI112081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rader D. J., Castro G., Zech L. A., Fruchart J. C., Brewer H. B., Jr In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J Lipid Res. 1991 Nov;32(11):1849–1859. [PubMed] [Google Scholar]
  37. Rosseneu M., Michiels G., De Keersgieter W., Bury J., De Slypere J. P., Dieplinger H., Utermann G. Quantification of human apolipoprotein A-IV by "sandwich"-type enzyme-linked immunosorbent assay. Clin Chem. 1988 Apr;34(4):739–743. [PubMed] [Google Scholar]
  38. Savion N., Gamliel A. Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells. Arteriosclerosis. 1988 Mar-Apr;8(2):178–186. doi: 10.1161/01.atv.8.2.178. [DOI] [PubMed] [Google Scholar]
  39. Schaefer E. J., Zech L. A., Jenkins L. L., Bronzert T. J., Rubalcaba E. A., Lindgren F. T., Aamodt R. L., Brewer H. B., Jr Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 1982 Aug;23(6):850–862. [PubMed] [Google Scholar]
  40. Sloop C. H., Dory L., Krause B. R., Castle C., Roheim P. S. Lipoproteins and apolipoproteins in peripheral lymph of normal and cholesterol-fed dogs. Atherosclerosis. 1983 Oct;49(1):9–21. doi: 10.1016/0021-9150(83)90003-5. [DOI] [PubMed] [Google Scholar]
  41. Stein O., Stein Y., Lefevre M., Roheim P. S. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta. 1986 Aug 14;878(1):7–13. doi: 10.1016/0005-2760(86)90337-1. [DOI] [PubMed] [Google Scholar]
  42. Steinmetz A., Barbaras R., Ghalim N., Clavey V., Fruchart J. C., Ailhaud G. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem. 1990 May 15;265(14):7859–7863. [PubMed] [Google Scholar]
  43. Steinmetz A., Clavey V., Vu-Dac N., Kaffarnik H., Fruchart J. C. Purification of human apolipoprotein A-IV by fast protein liquid chromatography. J Chromatogr. 1989 Jan 27;487(1):154–160. doi: 10.1016/s0378-4347(00)83018-2. [DOI] [PubMed] [Google Scholar]
  44. Steinmetz A., Czekelius P., Thiemann E., Motzny S., Kaffarnik H. Changes of apolipoprotein A-IV in the human neonate: evidence for different inductions of apolipoproteins A-IV and A-I in the postpartum period. Atherosclerosis. 1988 Jan;69(1):21–27. doi: 10.1016/0021-9150(88)90285-7. [DOI] [PubMed] [Google Scholar]
  45. Steinmetz A., Utermann G. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem. 1985 Feb 25;260(4):2258–2264. [PubMed] [Google Scholar]
  46. Tenkanen H., Lukka M., Jauhiainen M., Metso J., Baumann M., Peltonen L., Ehnholm C. The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360. Arterioscler Thromb. 1991 Jul-Aug;11(4):851–856. doi: 10.1161/01.atv.11.4.851. [DOI] [PubMed] [Google Scholar]
  47. Utermann G., Beisiegel U. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem. 1979 Sep;99(2):333–343. doi: 10.1111/j.1432-1033.1979.tb13261.x. [DOI] [PubMed] [Google Scholar]
  48. Utermann G., Feussner G., Franceschini G., Haas J., Steinmetz A. Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. J Biol Chem. 1982 Jan 10;257(1):501–507. [PubMed] [Google Scholar]
  49. Warnick G. R., Cheung M. C., Albers J. J. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem. 1979 Apr;25(4):596–604. [PubMed] [Google Scholar]
  50. Weinberg R. B., Dantzker C., Patton C. S. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology. 1990 Jan;98(1):17–24. doi: 10.1016/0016-5085(90)91285-e. [DOI] [PubMed] [Google Scholar]
  51. Weinberg R. B., Ibdah J. A., Phillips M. C. Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface. A model for its labile binding to high density lipoproteins. J Biol Chem. 1992 May 5;267(13):8977–8983. [PubMed] [Google Scholar]
  52. Weinberg R. B., Jordan M. K., Steinmetz A. Distinctive structure and function of human apolipoprotein variant ApoA-IV-2. J Biol Chem. 1990 Oct 25;265(30):18372–18378. [PubMed] [Google Scholar]
  53. Weinberg R. B., Patton C. S. Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta. 1990 May 22;1044(2):255–261. doi: 10.1016/0005-2760(90)90311-k. [DOI] [PubMed] [Google Scholar]
  54. Weinberg R. B., Scanu A. M. Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum. J Lipid Res. 1983 Jan;24(1):52–59. [PubMed] [Google Scholar]
  55. Weinberg R. B., Spector M. S. The self-association of human apolipoprotein A-IV. Evidence for an in vivo circulating dimeric form. J Biol Chem. 1985 Nov 15;260(26):14279–14286. [PubMed] [Google Scholar]
  56. Weisgraber K. H., Bersot T. P., Mahley R. W. Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein. Biochem Biophys Res Commun. 1978 Nov 14;85(1):287–292. doi: 10.1016/s0006-291x(78)80041-2. [DOI] [PubMed] [Google Scholar]
  57. Williams S. C., Grant S. G., Reue K., Carrasquillo B., Lusis A. J., Kinniburgh A. J. cis-acting determinants of basal and lipid-regulated apolipoprotein A-IV expression in mice. J Biol Chem. 1989 Nov 15;264(32):19009–19016. [PubMed] [Google Scholar]
  58. Wu A. L., Windmueller H. G. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem. 1979 Aug 10;254(15):7316–7322. [PubMed] [Google Scholar]
  59. de Knijff P., Rosseneu M., Beisiegel U., de Keersgieter W., Frants R. R., Havekes L. M. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res. 1988 Dec;29(12):1621–1627. [PubMed] [Google Scholar]
  60. von Eckardstein A., Funke H., Schulte M., Erren M., Schulte H., Assmann G. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet. 1992 May;50(5):1115–1128. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES